As ARIs share similar clinical features and various respiratory viruses trigger a variety of interferon-stimulated genes (ISGs), an ideal dataset for biomarker discovery should include not only influenza infections, but also other respiratory infections. This evidence concerns the gene STING1 and respiratory tract infectious disorder.